SeekingAlpha · Mar 3, 2026
OraSure Technologies, Inc. 2025 Q4 - Results - Earnings Call Presentation
2026-03-03. The following slide deck was published by OraSure Technologies, Inc.
NASDAQ · OSUR
OraSure Technologies, Inc.
Healthcare · Medical - Instruments & Supplies
$3.46
Up+$0.08 (+2.17%)
Updated Nov 4, 2026, 12:45 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 190.93M
- P/E ratio
- -3.75
- Dividend yield
- 0.00%
- 52-week range
- $2.78 – $4.58
- Volume
- 862.78K
- Avg. volume
- 642.43K
Price performance · OSUR
OSUR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
OSUR closed at $3.46 after 20 trading sessions, down 8.36% for the selected period.
- Last close
- $3.46
- Period change
- -8.36%
- Period low
- $3.46
- Period high
- $4.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $3.94 | $4.00 | $3.455 | $3.455 | 862.78K |
| Oct 30, 2026 | $4.07 | $4.10 | $3.92 | $3.94 | 609.39K |
| Oct 29, 2026 | $4.11 | $4.19 | $3.98 | $4.08 | 1.23M |
| Oct 28, 2026 | $4.15 | $4.215 | $4.0518 | $4.10 | 792.22K |
| Oct 27, 2026 | $4.18 | $4.265 | $4.04 | $4.16 | 869.72K |
| Oct 26, 2026 | $4.16 | $4.38 | $4.06 | $4.17 | 1.02M |
| Oct 23, 2026 | $3.95 | $4.175 | $3.885 | $4.13 | 1.16M |
| Oct 22, 2026 | $3.85 | $3.96 | $3.75 | $3.80 | 538.59K |
| Oct 21, 2026 | $3.75 | $3.88 | $3.742 | $3.86 | 404.32K |
| Oct 20, 2026 | $3.70 | $3.785 | $3.675 | $3.745 | 406.44K |
| Oct 19, 2026 | $3.61 | $3.70 | $3.59 | $3.68 | 659.17K |
| Oct 16, 2026 | $3.82 | $3.83 | $3.61 | $3.61 | 317.87K |
| Oct 15, 2026 | $3.72 | $3.83 | $3.7124 | $3.81 | 590.89K |
| Oct 14, 2026 | $3.77 | $3.81 | $3.71 | $3.71 | 355.98K |
| Oct 13, 2026 | $3.93 | $3.975 | $3.79 | $3.81 | 559.68K |
| Oct 12, 2026 | $3.90 | $3.995 | $3.895 | $3.92 | 462.23K |
| Oct 9, 2026 | $3.78 | $3.93 | $3.78 | $3.90 | 446.8K |
| Oct 8, 2026 | $3.70 | $3.86 | $3.695 | $3.795 | 584.28K |
| Oct 7, 2026 | $3.74 | $3.86 | $3.6265 | $3.73 | 435.06K |
| Oct 6, 2026 | $4.11 | $4.13 | $3.765 | $3.77 | 534.07K |
Latest OSUR news
The latest Smart Investors Daily articles mentioning OSUR.
Stock researchCompany · Overview
Company
Market Activity
Research & News
OSUR research
Overview
Company profile and research snapshot.
Company profile
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $4.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 12, 2025 | Stephens & Co. | Equal-Weight | — |
| May 19, 2025 | Evercore ISI Group | In-Line | — |
| Aug 7, 2024 | Evercore ISI Group | In-Line | — |
| Jul 2, 2024 | Evercore ISI Group | In-Line | — |
| May 13, 2024 | JP Morgan | Neutral | — |
News briefing
No generated briefing is available yet.
Benzinga · Feb 26, 2026
OraSure Technologies shares are trading higher after the company reported better-than-expected Q4 financial results.
ChartMill · Feb 26, 2026
OraSure Technologies Inc (NASDAQ:OSUR) Reports Mixed Q4 2025 Results Amid Strategic Transition
OraSure posts mixed Q4 results with revenue beat but deeper core decline. Focus shifts to 2026 growth from new pipeline products like CT/NG self-test.
SeekingAlpha · Feb 25, 2026
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
